Photodynamic therapy of necrobiosis lipoidica--a multicenter study of 18 patients.

Necrobiosis lipoidica (NL) is a granulomatous skin disease of unknown origin, and no reliably effective treatment option exists to handle this often disfiguring disease. Recently, a patient with long-lasting NL was reported to be cured by topical photodynamic therapy (PDT).
To evaluate the overall potential of PDT in the treatment of NL on the lower legs.
Retrospective study of 18 patients (aged 16-62 years) from 3 European university departments of dermatology treated with PDT for NL. Methyl aminolevulinate or 5-aminolevulinic acid were used as topically applied photosensitizers. Illumination followed with red light-emitting diode light.
Complete response was seen in 1/18 patients after 9 PDT cycles, and partial response in 6/18 patients (2-14 PDT cycles) giving an overall response rate of 39% (7/18).
Although almost 40% of the cases showed some degree of response, PDT cannot currently be recommended as first-line therapy of NL. Subpopulations of therapy-resistant NL patients may, however, benefit from PDT.
AuthorsC Berking, J Hegyi, P Arenberger, T Ruzicka, G B E Jemec
JournalDermatology (Basel, Switzerland) (Dermatology) Vol. 218 Issue 2 Pg. 136-9 ( 2009) ISSN: 1421-9832 [Electronic] Switzerland
PMID19060464 (Publication Type: Journal Article, Multicenter Study)
CopyrightCopyright (c) 2008 S. Karger AG, Basel.
Chemical References
  • Photosensitizing Agents
  • methyl 5-aminolevulinate
  • Aminolevulinic Acid
  • Administration, Cutaneous
  • Adolescent
  • Adult
  • Aminolevulinic Acid (administration & dosage, analogs & derivatives)
  • Czech Republic
  • Denmark
  • Female
  • Germany
  • Humans
  • Leg (pathology)
  • Male
  • Middle Aged
  • Necrobiosis Lipoidica (drug therapy, pathology)
  • Photochemotherapy (methods)
  • Photosensitizing Agents (administration & dosage)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: